Why the CLIMB Act cannabis stock exchanges push matters for U.S. listings, capital access, and Arizona operators even if rescheduling moves ahead.

Arizona cannabis brands are competing with national names by leaning into local roots, quality flower, concentrates, edibles and dispensary loyalty.

Schedule III marijuana reshapes taxes, research, and federal oversight for licensed medical cannabis while adult-use remains outside the immediate order.

Federal hemp rules may shrink hemp beverages nationally and redirect demand toward local, compliance-first operators and regulated cannabis channels.

The penny shortage is pushing dispensaries into cash rounding that can trigger receipt gaps, reconciliation headaches and compliance scrutiny.

Section 280E Constitutionality Challenges to the Federal Marijuana Tax Rule Face Steep Legal Hurdles

Early 2026 shows renewed pressure on cannabis reform as SAM, state AGs, and lawsuits shape a new phase of anti-legalization resistance.

THC beverages are turning Dry January experiments into year-round habits as drinkers rethink alcohol, retailers adapt and new hemp rules reshape the market.

How S4509 rewrites New Jersey’s hemp rules, opens a tightly regulated path for THC beverages in liquor stores, and positions the state ahead of a sweeping federal hemp crackdown.

Rescheduling marijuana shifts research and business rules, but leaves federal legality in limbo

How Trump’s marijuana rescheduling directive and a potential Medicare CBD framework could reshape federal drug policy, senior care and the Arizona cannabis industry at the same time.

A look at how cannabis and winter traditions intersect through ritual, history, and shared sensory experiences that have shaped the season for centuries.